//
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Commonwealth legislation
This Act has been repealed and is no longer in force. It is retained for historical reference.
This pricing determination under the National Health Act fixes the official wholesale (manufacturer’s) prices for specific branded medicines subsidised on the PBS, replacing the March 2005 schedule and commencing 1 August 2005. It sets brand‑specific prices and covered quantities, notes special “authority prescription” conditions for some items, and includes transitional (grandfathering) protection for four drugs until 1 March 2006.
It affects pharmaceutical companies, pharmacists who buy PBS stock, and patients whose out‑of‑pocket costs reflect these prices.
Want the full deep dive?
Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.
Direct links to the current provisions in National Health Act 1953 - Determination under subsection 85B(1) (No. PB 19 of 2005).
Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.
PBS Determination 85BCOMMONWEALTH OF AUSTRALIA
National Health Act 1953
PHARMACEUTICAL BENEFITS
DETERMINATION UNDER SUBSECTION 85B(1)
No. PB 19 of 2005
I, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, pursuant to subsection 85B(1) of the National Health Act 1953 (referred to in this Determination as “the Act”), hereby make the following Determination:
This Determination commences on 1 August 2005.
Determination No. PB 5 of 2005 under subsection 85B(1) of the National Health Act 1953, made on 22 March 2005 with effect from 1 April 2005, is repealed.
In this Determination “authority prescription” means a prescription which directs the supply of a pharmaceutical benefit and is a prescription authorised in accordance with paragraph 12 of the determinations made under sections 85, 85A and 88 of the Act.
Section 85B of the Act applies in relation to each of the brands of the pharmaceutical benefits specified in Part A of the Schedule to this Determination (referred to in this Determination as “the Schedule”).
For the purposes of paragraph 85B(1)(c) of the Act, the quantity or number of units that is relevant for the purpose of determining an amount referred to in paragraph 85B (1) (d) or 85B(1)(e) of the Act in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the quantity or number of units specified in Part B of the Schedule in relation to the brand of the pharmaceutical benefit.
For the purposes of paragraph 85B(1)(d) of the Act, the amount that is, for the purposes of Part VII of the Act, to be taken to be the manufacturer’s price for sales to approved pharmacists in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the amount specified in Part C of the Schedule in relation to the brand of the pharmaceutical benefit.
For the purposes of paragraph 85B(1)(e) of the Act, the amount that is, for the purposes of Part VII of the Act, to be taken to be the price claimed by the manufacturer as the manufacturer’s price for sales to approved pharmacists in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the amount specified in Part D of the Schedule in relation to the brand of the pharmaceutical benefit.
Notwithstanding anything else in this Determination, section 85B of the Act will not apply in respect of the pharmaceutical benefits listed in the following table if the prescription which directs the supply of the pharmaceutical benefit was written before 1 August 2005 and supply is made before 1 March 2006:
| Drug or medicinal preparations | Form (strength, type, size, etc) | Brand |
|---|---|---|
| Escitalopram Oxalate | Tablet equivalent to 10 mg escitalopram | LU |
| Tablet equivalent to 20 mg escitalopram | LU | |
| Levetiracetam | Tablet 250 mg | UC |
| Tablet 500 mg | UC | |
| Tablet 1 g | UC | |
| Pemetrexed Disodium Heptahydrate | Powder for I.V. infusion equivalent to 500 mg pemetrexed, vial | LY |
| Topiramate | Tablet 25 mg | JC |
| Tablet 50 mg | JC | |
| Tablet 100 mg | JC | |
| Tablet 200 mg | JC | |
| Capsule 15 mg | JC | |
| Capsule 25 mg | JC | |
| Capsule 50 mg | JC |
| Letters | Manufacturer's Name | Letters | Manufacturer's Name |
|---|
| AB | Abbott Australasia Pty Ltd |
|---|---|
| AD | Amrad Pharmaceuticals Pty Ltd |
| AG | Allergan Australia Pty Ltd |
| AL | Alphapharm Medical A Division of Alphapharm Pty Limited |
| AP | AstraZeneca Pty Ltd |
| AQ | Alcon Laboratories (Australia) Pty Ltd |
| AS | Aspen Pharmacare Australia Pty Ltd |
| AV | Aventis Pharma Pty Limited |
| AW | Arrow Pharmaceuticals Limited |
| BN | Bayer Australia Limited |
| BP | British Pharmaceuticals |
| BQ | Bristol-Myers Squibb Pharmaceuticals A Division of Bristol-Myers Squibb Australia Pty Ltd |
| BX | Baxter Healthcare Pty Limited |
| BY | Boehringer Ingelheim Pty Limited |
| CS | CSL Limited |
| EX | Essex Laboratories |
| FR | Charles E. Frosst Division of Merck Sharp & Dohme (Australia) Pty Ltd |
| GC | GlaxoSmithKline Consumer Healthcare |
| GK | GlaxoSmithKline Australia Pty Ltd |
| ID | ICN Pharmaceuticals Australasia Pty Ltd |
| JC | Janssen-Cilag Pty Ltd |
| KN | Knoll A Division of Abbott Australasia Pty Ltd |
| LU | Lundbeck Australia Pty Ltd |
| LY | Eli Lilly Australia Pty Limited |
| MK | Merck Sharp & Dohme (Australia) Pty Ltd |
| MM | 3M Pharmaceuticals Australia Pty Ltd |
| MX | Mayne Pharma Pty Ltd |
| NV | Novartis Pharmaceuticals Australia Pty Ltd |
| OR | Organon (Australia) Pty Limited |
| PF | Pfizer Pty Limited |
| PH | Pharmacia Australia Pty Limited |
| RO | Roche Products Pty Ltd |
| SC | Schering Pty Ltd Australian Subsidiary of Schering AG, Berlin |
| SE | Servier Laboratories (Aust.) Pty Ltd |
| SG | Serono Australia Pty Ltd |
| SI | Sigma Pharmaceuticals Pty Ltd |
| SM | Solvay Pharmaceuticals Division of Solvay Biosciences Pty Ltd |
| SU | Sauter Laboratories (Aust.) Pty Ltd |
| SW | Sanofi-Synthelabo Australia Pty Limited |
| SZ | Sandoz Pty Ltd |
| UC | UCB Pharma A Division of UCB Australia Pty Ltd |
| WR | Warner Lambert Consumer Healthcare Pty Ltd |
| WY | Wyeth Pharmaceuticals Division of Wyeth Australia Pty Limited |
| ZH | Shinnick Pharmaceuticals Pty Limited |
<table cellspacing="0" cellpadding="0" style="margin-top:0pt; margin-bottom:0pt; border-collapse:collapse"><tbody><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><a id="bmk85Bs1"><span>Aciclovir</span></a></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Tablet 200</span><span> </span><span>mg</span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>GK</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>25</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>45.17</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>47.80</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span></span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span></span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>GK</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>90</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>165.31</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>169.20</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span></span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Tablet 800</span><span> </span><span>mg</span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>GK</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>35</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>200.27</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>202.36</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span></span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span></span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>GK</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>120</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>664.38</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>671.30</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Allopurinol</span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Tablet 100</span><span> </span><span>mg</span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>SI</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>200</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>8.11</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>10.32</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span></span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Tablet 300</span><span> </span><span>mg</span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>SI</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>60</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>4.80</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>6.87</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Alprazolam</span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Tablet 250</span><span> </span><span>micrograms</span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>PH</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>50</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>3.74</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>4.72</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span></span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Tablet 500</span><span> </span><span>micrograms</span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>PH</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>50</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTa
This is an opening excerpt, not the complete document.